Literature DB >> 17956461

Atherogenic lipoprotein parameters in patients with aggressive periodontitis.

M L Rufail1, H A Schenkein, T E Koertge, A M Best, S E Barbour, J G Tew, R van Antwerpen.   

Abstract

BACKGROUND AND
OBJECTIVE: Certain types of chronic infection increase the plasma level of very-low-density lipoprotein, leading to formation of the particularly atherogenic low-density lipoprotein subclass, small dense low-density lipoprotein. In the present study, we examined whether aggressive forms of periodontitis are associated with these atherogenic lipoprotein parameters.
MATERIAL AND METHODS: Twelve healthy control subjects without periodontitis, 12 subjects with localized aggressive periodontitis and 12 subjects with generalized aggressive periodontitis were studied. Lipoprotein subclass levels were determined using nuclear magnetic resonance methodology.
RESULTS: Healthy control subjects, localized aggressive periodontitis subjects and generalized aggressive periodontitis subjects had progressively higher plasma levels of very-low-density lipoprotein and progressively smaller average low-density lipoprotein size (p < 0.05, one-way analysis of variance). In pairwise comparisons, differences were only significant between healthy controls and generalized aggressive periodontitis subjects (p < 0.05, Tukey's post test). After adjustment for body mass index, the mean periodontal pocket depth correlated positively with plasma very-low-density lipoprotein levels (p = 0.047). Very-low-density lipoprotein concentrations correlated positively with small dense low-density lipoprotein levels and negatively with average low-density lipoprotein size. Prevalence of the atherogenic lipoprotein pattern-B in healthy controls, localized aggressive periodontitis subjects and generalized aggressive periodontitis subjects was 8.3%, 33.3% and 66.6%, respectively.
CONCLUSION: These results indicate that periodontal infection is associated with elevated plasma levels of atherogenic lipoprotein species. This association may account for the increased risk of periodontitis patients for cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17956461     DOI: 10.1111/j.1600-0765.2007.00973.x

Source DB:  PubMed          Journal:  J Periodontal Res        ISSN: 0022-3484            Impact factor:   4.419


  7 in total

Review 1.  Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases.

Authors:  Harvey A Schenkein; Bruno G Loos
Journal:  J Clin Periodontol       Date:  2013-04       Impact factor: 8.728

2.  Lipoproteins and lipoprotein metabolism in periodontal disease.

Authors:  Rachel Griffiths; Suzanne Barbour
Journal:  Clin Lipidol       Date:  2010-06

Review 3.  Periodontal disease and risk of atherosclerotic coronary heart disease.

Authors:  Takako Nakajima; Kazuhisa Yamazaki
Journal:  Odontology       Date:  2009-07-29       Impact factor: 2.634

4.  Chronic oral infection with Porphyromonas gingivalis accelerates atheroma formation by shifting the lipid profile.

Authors:  Tomoki Maekawa; Naoki Takahashi; Koichi Tabeta; Yukari Aoki; Hirotaka Miyashita; Sayuri Miyauchi; Haruna Miyazawa; Takako Nakajima; Kazuhisa Yamazaki
Journal:  PLoS One       Date:  2011-05-19       Impact factor: 3.240

5.  Periodontal, metabolic, and cardiovascular disease: Exploring the role of inflammation and mental health.

Authors:  Mark A Reynolds; Anwar T Merchant; Teodor T Postolache; Hina Makkar; Abhishek Wadhawan; Aline Dagdag
Journal:  Pteridines       Date:  2018-11-13       Impact factor: 0.581

Review 6.  Periodontitis as a risk factor of atherosclerosis.

Authors:  Jirina Bartova; Pavla Sommerova; Yelena Lyuya-Mi; Jaroslav Mysak; Jarmila Prochazkova; Jana Duskova; Tatjana Janatova; Stepan Podzimek
Journal:  J Immunol Res       Date:  2014-03-23       Impact factor: 4.818

7.  Relationship between the burden of major periodontal bacteria and serum lipid profile in a cross-sectional Japanese study.

Authors:  Youn-Hee Choi; Takayuki Kosaka; Miki Ojima; Shinichi Sekine; Yoshihiro Kokubo; Makoto Watanabe; Yoshihiro Miyamoto; Takahiro Ono; Atsuo Amano
Journal:  BMC Oral Health       Date:  2018-05-04       Impact factor: 2.757

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.